Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: October 2017

10/24/2017 Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (September 2017)

Between January and September 2017, Russian manufacturers produced and dispatched 241.3 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 7.2% higher than that of the same period of 2016. In physical terms, the dispatch volume amounted 3.08 bln units, which is only 2.1% higher than that of the same period of 2016.

10/13/2017 Database Update: Pharmaceutical Drug Import to Russia (September 2017)

During the first three quarters of 2017, Russia imported 372.2 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms 9.5% higher than that of the same period of 2016. Then-bulk imports amounted to 70.1 bln RUB, which is 18% lower than that of the same period of 2016, despite the progress in August. Since January 2017, Russia has imported 442.3 bln RUB worth of pharmaceuticals, with the growth rates amounting to 3.9%, which barely cover the inflationary factor.